Christopher J. Centeno, M.D. is a specialist in regenerative medicine and has helped found the emerging specialty of Interventional Orthobiologics. He has had many world-wide and U.S. procedural firsts in Orthobiologics and is CMO of Regenexx and a founding member of the Interventional Orthopedics Foundation (IOF).

He is one of the few physicians in the world with extensive experience in the culture expansion of and clinical use of adult stem cells to treat orthopedic injuries. He is responsible for the world’s largest and oldest stem cell treatment registry focused in the field of orthopedic injuries.

His clinic incorporates a variety of Orthobiologic injections that are delivered via precision, image guidance to help patients from all over the world avoid more invasive orthopedic surgery. Dr. Centeno also runs lab and clinical research groups that have the benefit of a state of the art cell biology research facility.

Dr. Centeno has chaired multiple international research based conferences. He also maintains an active research based practice, producing multiple publications per year that are listed in the US National Library of Medicine. Dr. Centeno has also served as editor-in-chief of a medical research journal dedicated to traumatic injury and serves as a peer reviewer for multiple research publications. He has lectured all over the world on regenerative therapies including twice at the Vatican in Rome.

Dr. Centeno trained at the Baylor College of Medicine, Texas Medical Center and the Institute for Rehabilitation Research. He hails from both Florida and New York and currently resides in Boulder, Colorado with his wife and three children.